CircMIRLET7BHG facilitates mast cell degranulation to accelerate allergic rhinitis progression by enhancing IL-33

Jiabin Zhan1, Rui Li1, Yisen Liang2

  • 1Department of Otorhinolaryngology Head and Neck Surgery, Hainan General Hospital (Hainan Affiliated Hospital of Hainan Medical University), Haikou City, Hainan Province, P.R. China.

Abstract

Insights

Circular RNA MIRLET7BHG promotes allergic rhinitis (AR) by enhancing mast cell degranulation and mitochondrial fission via the PTBP1/IL-33 pathway. This highlights circMIRLET7BHG as a potential therapeutic target for AR.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Biology

Background:

  • Mast cell degranulation is crucial in allergic rhinitis (AR) progression.
  • The role of circMIRLET7BHG in mast cell degranulation during AR remains unclear.

Purpose of the Study:

  • To investigate the regulatory role of circMIRLET7BHG in mast cell degranulation and mitochondrial dynamics in AR.
  • To elucidate the underlying molecular mechanisms involving PTBP1 and IL-33.

Main Methods:

  • Co-culture of mast cells (LAD2) with ovalbumin (OVA)-induced human nasal epithelial cells (HNEpC).
  • Generation of an OVA-induced AR mouse model.
  • Assessment of circMIRLET7BHG, IL-33, PTBP1 expression, cytokine production, and mitochondrial dynamics.
  • RNA immunoprecipitation and pull-down assays to confirm molecular interactions.

Main Results:

  • circMIRLET7BHG knockdown inhibited mast cell degranulation and mitochondrial fission.
  • circMIRLET7BHG stabilized IL-33 mRNA via PTBP1 interaction, promoting mitochondrial fission and degranulation.
  • In AR models, circMIRLET7BHG aggravated symptoms by increasing epithelial thickness, eosinophil infiltration, and apoptosis.

Conclusions:

  • circMIRLET7BHG promotes AR progression by enhancing mitochondrial fission and mast cell degranulation.
  • The PTBP1/IL-33 axis is a key mediator of circMIRLET7BHG's effects in AR.
  • circMIRLET7BHG represents a potential therapeutic target for allergic rhinitis.